Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank79
Studio
Year-over-Year Change

Diluted earnings per share

Percentile
P79
Within normal range
vs 2Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM5.83+2750.0%
2024-0.22-107.5%
20232.94+248.5%
2022-1.98-159.3%
20213.34+1955.6%
2020-0.18-100.6%
201931.85+434.4%
20185.96+1024.5%
20170.53+775.2%
2016-0.08-